Mounting evidence suggests that non-steroidal anti-inflammatory drugs may be useful in reducing the risk of Alzheimer disease. After much study, the mechanism by which these drugs reduce the amyloid deposition associated with the disease is still open to speculation.
This is a preview of subscription content, log in via an institution to check access.
References
Akiyama, H. et al. Inflammation and Alzheimer's disease. Neuroinflammation working group. Neurobiol. Aging 21, 383–421 (2000).
Lim, G.P. et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J. Neurosci. 20, 5709–5714 (2000).
Kisilevsky, R. & Fraser, P. E. Aβ amyloidogenesis: unique, or variation on a systemic theme? Crit. Rev. Biochem. Mol. Biol. 32, 361–404 (1997).
Younkin, S.G. Evidence that Aβ42 is the real culprit in Alzheimer's disease. Ann. Neurol. 37, 287–288 (1995).
Yankner, B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921–932 (1996).
Selkoe, D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399 (Suppl), A23–31 (1999).
Kaufmann, W.E., Andreasson, K.I., Isakson, P.C. & Worley, P.F. Cyclooxygenases and the central nervous system. Prostaglandins 54, 601–624 (1997).
Lehmann, J.M., Lenhard, J.M., Oliver, B.B., Ringold, G.M. & Kliewer, S.A. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272, 3406–3410 (1997).
Mucke, L. et al. High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050–4058 (2000).
Bales, K.R. et al. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nature Genet. 17, 263–264 (1997).
Yan, S.D., Roher, A., Schmidt, A.M. & Stern, D.M. Cellular cofactors for amyloid β-peptide-induced cell stress. Moving from cell culture to in vivo. Am. J. Pathol. 155, 1403–1411 (1999).
Schenk, D. et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173–177 (1999).
Flaris, N.A., Densmore, T.L., Molleston, M.C. & Hickey, W.F. Characterization of microglia and macrophages in the central nervous system of rats: definition of the differential expression of molecules using standard and novel monoclonal antibodies in the normal CNS and in four models of parenchymal reaction. Glia 7, 34–40 (1993).
Hsia, A. et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA 96, 3228–3233 (1999).
Lue, L.-F. et al. Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853–862 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wyss-Coray, T., Mucke, L. Ibuprofen, inflammation and Alzheimer disease. Nat Med 6, 973–974 (2000). https://doi.org/10.1038/79661
Issue Date:
DOI: https://doi.org/10.1038/79661
- Springer Nature America, Inc.